Diagnostic role of endothelial microparticles in vasculitis

Rheumatology

Volumn 47, Issue 12, 2008, Pages 1820-1825

  Erdbruegger, Uta ^a   Grossheim, M ^a   Hertel, B ^a   Wyss, K ^a   Kirsch, T ^a   Woywodt, A ^b   Haller, H ^a   Haubitz, M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

ANCA associated vasculitis; Circulating endothelial cells; Endothelium; Laboratory markers; Microparticles

Indexed keywords

ENDOGLIN; IMMUNOSUPPRESSIVE AGENT; LIPOCORTIN 5; PADGEM PROTEIN;

ADULT; ANCA ASSOCIATED VASCULITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; ENDOTHELIAL MICROPARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOMAGNETIC SEPARATION; LEUKOCYTE COUNT; MALE; PATHOGENESIS; PRIORITY JOURNAL; REMISSION; SCORING SYSTEM; THROMBOCYTE COUNT; ULTRACENTRIFUGE;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; BLOOD SPECIMEN COLLECTION; CELL-DERIVED MICROPARTICLES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; VASCULITIS;

EID: 56649111435     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken373     Document Type: Article

References (37)

1. Blann AD, Woywodt A, Bertolini F et al. Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost 2005;93:228-35.
2. Finkielman JD, Merkel PA, Schroeder D et al. Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis. Ann Intern Med 2007;147:611-9.
3. Woywodt A, Streiber F, de Groot K, Regelsberger H, Haller H, Haubitz M. Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis. Lancet 2003;361:206-10.
4. Haubitz M, Woywodt A. Circulating endothelial cells and vasculitis. Intern Med 2004;43:660-7.
5. Woywodt A, Goldberg C, Kirsch T et al. Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA associated vasculitis. Ann Rheum Dis 2006;65:164-8.
6. Ahn YS. Cell-derived microparticles: 'miniature envoys with many faces'. J Thromb Haemost 2005;3:884-7.
7. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007;21:157-71.
8. Ardoin SP, Shanahan JC, Pisetsky DS. The role of microparticles in inflammation and thrombosis. Scand J Immunol 2007;66:159-65.
9. Dignat-George F, Camoin-Jau L, Sabatier F et al. Endothelial microparticles: A potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thromb Haemost 2004;91:667-73.
10. Koga H, Sugiyama S, Kugiyama K et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2005;45:1622-30.
11. Brogan PA, Shah V, Brachet C et al. Endothelial and platelet microparticles in vasculitis of the young. Arthritis Rheum 2004;50:927-36.
12. Daniel L, Fakhouri F, Joly D et al. Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int 2006;69:1416-23.
13. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37: 187-92.
14. Luqmani RA, Bacon PA, Moots RJ et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994;87:671-8.
15. Woywodt A, Blann AD, Kirsch T et al. Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: Proposal of a definition and a consensus protocol. J Thromb Haemost 2006;4:671-7.
16. George F, Poncelet P, Laurent JC et al. Cytofluorometric detection of human endothelial cells in whole blood using S-Endo 1 monoclonal antibody. J Immunol Methods 1991;139:65-75.
17. Delorme B, Basire A, Gentile C et al. Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146± blood cells. Thromb Haemost 2005;94:1270-9.
18. Dignat-George F. J. CD146. Protein reviews on the web. 2003.
19. Hergesell O, Andrassy K, Nawroth P. Elevated levels of markers of endothelial cell damage and markers of activated coagulation in patients with systemic necrotizing vasculitis. Thromb Haemost 1996;75:892-8.
20. Hergesell O, Andrassy K, Geberth S, Nawroth P, Gabath S. Plasma thrombomodulin levels are dependent on renal function. Thromb Res 1993;72:455-8.
21. Barclay AN, Brown MH, Law SKA, McKnight AJ, Tomlinson MG, van der Merwe PA. (eds) CD105. The leukocyte antigen facts book. San Diego: Academic press, Harcourt Brace and Company, 1997:384-5.
22. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-101.
23. Radford DJ, Luu NT, Hewins P, Nash GB, Savage CO. Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells. Arthritis Rheum 2001;44:2851-61.
24. Coll-Vinent B, Cebrian M, Cid MC et al. Dynamic pattern of endothelial cell adhesion molecule expression in muscle and perineural vessels from patients with classic polyarteritis nodosa. Arthritis Rheum 1998;41:435-44.
25. Freyssinet JM, Dignat-George F. More on: Measuring circulating cell-derived microparticles. J Thromb Haemost 2005;3:613-4.
26. Jimenez JJ, Jy W, Mauro LM, Horstman LL, Soderland C, Ahn YS. Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation. Br J Haematol 2003;123:896-902.
27. Jennette JC, Xiao H, Falk RJ. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol 2006;17:1235-42.
28. Mesri M, Altieri DC. Endothelial cell activation by leukocyte microparticles. J Immunol 1998;161:4382-7.
29. Mesri M, Altieri DC. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem 1999;274:23111-8.
30. Gasser O, Hess C, Miot S, Deon C, Sanchez JC, Schifferli JA. Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. Exp Cell Res 2003;285:243-57.
31. Forlow SB, McEver RP, Nollert MU. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 2000;95:1317-23.
32. Fujimi S, Ogura H, Tanaka H et al. Activated polymorphonuclear leukocytes enhance production of leukocyte microparticles with increased adhesion molecules in patients with sepsis. J Trauma 2002;52:443-8.
33. Rauch U, Antoniak S. Tissue factor-positive microparticles in blood associated with coagulopathy in cancer. Thromb Haemost 2007;97:9-10.
34. Haubitz M, Gerlach M, Kruse HJ, Brunkhorst R. Endothelial tissue factor stimulation by proteinase 3 and elastase. Clin Exp Immunol 2001;126:584-8.
35. Gilbert GE, Sims PJ, Wiedmer T, Furie B, Furie BC, Shattil SJ. Platelet-derived micro-particles express high affinity receptors for factor VIII. J Biol Chem 1991;266:17261-8.
36. Lechner D, Kollars M, Gleiss A, Kyrle PA, Weltermann A. Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity. J Thromb Haemost 2007.
37. Merkel PA, Lo GH, Holbrook JT et al. Brief communication: High incidence of venous thrombotic events among patients with Wegener granulomatosis: The Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann Intern Med 2005;142:620-6.